AFT Pharmaceuticals Limited (AFP) Q2 2024 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day, my name is Krista and I'll be your conference operator today. At this time, I would like to welcome everyone to the fiscal year 2024 half-year results analyst briefing. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during that time, please press star followed by the number one on your telephone keypad. And if you would like to withdraw your question, again, press star one. Thank you. I will now turn the conference over to Hartley Atkinson, Managing Director. Hartley, you may begin your conference. Good. Thank you very much. And thank you, everyone, for joining us today. So just to do the usual format where we go through the investor presentation and then we have question time. So, look, just to start, just go through the page numbers. So we've got the cover page. which we're going through the results for our first half of the financial year, which ended the 30th of September. And on page two, we had the usual disclaimer, so please just be aware of those details on page two. Page three, the people presenting today will be a mixture of myself and also Malcolm Tubby, our Chief Financial Officer, will cover the financial pages of the presentation. So going to page number four, what we're looking at here is a summary of the overall results. I think what we're seeing as important was the business continued to grow well. and traditionally we've always grown in Australia and New Zealand, which again grew, but more significantly, we've always indicated we've been working very hard on Asia and also international, and we got 50% growth in Asia and 172% growth in international, where we pretty much exceeded, well, we did exceed last year's...